A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients
Esther Rodríguez‐Gallego(Institut de Recerca Biomèdica Catalunya Sud), Francesc Vidal(Institut de Recerca Biomèdica Catalunya Sud), Verònica Alba, Anna Rull(Institut de Recerca Biomèdica Catalunya Sud), Yolanda M. Pacheco(Instituto de Biomedicina de Sevilla), Manuel Leal(Apple (Israel)), Josep Gómez(Hospital Universitari Joan XXIII de Tarragona), Peré Domingo(Hospital de Sant Pau), Nicolau Cañellas(Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas), Consuelo Viladés(Hospital Universitario Fundación Jiménez Díaz), Xavier Correig(Universidad Rovira i Virgili), Julià Blanco(IrsiCaixa), Miguel López-Dupla, Sergi Veloso, Roger Mallol(Institut d'Investigació Sanitària Pere Virgili), Joaquim Peraire(Instituto de Salud Carlos III), Raúl Beltrán‐Debón(Institut de Recerca Biomèdica Catalunya Sud)
Cited by 42
Related Papers
Ultraviolet vision in lizards
|Nature|1993|257
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies
|Science Translational Medicine|2017|169
Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV‐1 envelope
|The EMBO Journal|2002|147
Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
|The Lancet Infectious Diseases|2015|143